Efficacy of dolutegravir-based therapy in achieving virological suppression in PLHIV in low- and middle-income countries: real-world evidence from a large clinical cohort in Cameroon

Abstract Background HIV treatment has significantly improved with the introduction of potent antiretroviral therapy (ART), particularly dolutegravir (DTG)-based regimens. With suboptimal adherence reported in resource-limited settings (RLS), real-word evidence on DTG-effectiveness within ART clinics...

詳細記述

書誌詳細

主要な著者:	Carine Tadenfok, Joseph Fokam, Ezechiel Ngoufack Jagni Semengue, Leonella Mossiang, Steve Oyie, Pascaline Noumo, Judith Ngia, Grace Angong Beloumou, Sandrine Claire Djupsa Ndjeyep, Alex Durand Nka, Collins Chenwi Ambe, Aude Christelle Ka’e, Desire Takou, Derrick Tambe Ayuk Ngwese, Tatiana Tekoh Anim-keng, Lum Forgwei, Angeline Kengne, Bouba Yagai, Elise Elong Lobe, Ariane Feukeng, Rogers Ajeh Awoh, Anne-Cecile ZK Bissek, Marius Vouking, Alexis Ndjolo, Nicaise Ndembi, Carlo-Federico Perno, Charles Kouanfack, Celine Nkenfou
フォーマット:	Artigo
言語:	Inglês
出版事項:	BMC 2026-03-01
シリーズ:	BMC Infectious Diseases
主題:	Dolutegravir HIV epidemic control Low-middle income countries Cameroon
オンライン･アクセス:	https://doi.org/10.1186/s12879-026-13013-2
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!